Annovis Bio, Inc.
N/A
USD
N/A
N/A
...
Chart
Financials
Description
ANVS Company Description
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.
ANVS Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view ANVS Smart Score
Score Breakdown
ANVS Company Description
Show More
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of ANVS by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ANVS's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on ANVS's company Twitter account
WallStreetBets
Number of mentions of ANVS in WallStreetBets Daily Discussion
ANVS News
Recent insights relating to ANVS
CNBC Recommendations
Recent picks made for ANVS stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in ANVS
Corporate Flights
Flights by private jets registered to ANVS
Our Analysis